ATE502123T1 - Verfahren und zusammensetzungen zur diagnose und behandlung von krebs - Google Patents

Verfahren und zusammensetzungen zur diagnose und behandlung von krebs

Info

Publication number
ATE502123T1
ATE502123T1 AT07813073T AT07813073T ATE502123T1 AT E502123 T1 ATE502123 T1 AT E502123T1 AT 07813073 T AT07813073 T AT 07813073T AT 07813073 T AT07813073 T AT 07813073T AT E502123 T1 ATE502123 T1 AT E502123T1
Authority
AT
Austria
Prior art keywords
diagnosis
compositions
treatment
methods
cancer
Prior art date
Application number
AT07813073T
Other languages
German (de)
English (en)
Inventor
John Chant
Anthony S Guerrero
Peter Haverty
Cynthia Honchell
Kenneth Jung
Thomas D Wu
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE502123T1 publication Critical patent/ATE502123T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07813073T 2006-07-19 2007-07-18 Verfahren und zusammensetzungen zur diagnose und behandlung von krebs ATE502123T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80779406P 2006-07-19 2006-07-19
PCT/US2007/073811 WO2008011482A2 (en) 2006-07-19 2007-07-18 Methods and compositions for the diagnosis and treatment of cancer

Publications (1)

Publication Number Publication Date
ATE502123T1 true ATE502123T1 (de) 2011-04-15

Family

ID=38957597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07813073T ATE502123T1 (de) 2006-07-19 2007-07-18 Verfahren und zusammensetzungen zur diagnose und behandlung von krebs

Country Status (8)

Country Link
US (2) US20100028365A1 (https=)
EP (1) EP2041320B1 (https=)
JP (1) JP5297375B2 (https=)
AT (1) ATE502123T1 (https=)
CA (1) CA2658319A1 (https=)
DE (1) DE602007013234D1 (https=)
ES (1) ES2361950T3 (https=)
WO (1) WO2008011482A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110030074A1 (en) * 2007-05-21 2011-02-03 Dana Farber Cancer Institute, Inc. Compositions and methods for cancer gene discovery
WO2012135696A2 (en) * 2011-04-01 2012-10-04 University Of South Alabama Methods and compositions for the diagnosis, classification, and treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047152A2 (en) * 1998-03-20 1999-09-23 Sloan Kettering Institute For Cancer Research Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells
US20030049203A1 (en) * 2001-08-31 2003-03-13 Elmaleh David R. Targeted nucleic acid constructs and uses related thereto

Also Published As

Publication number Publication date
JP5297375B2 (ja) 2013-09-25
WO2008011482A3 (en) 2008-04-03
CA2658319A1 (en) 2008-01-24
EP2041320B1 (en) 2011-03-16
WO2008011482A2 (en) 2008-01-24
EP2041320A2 (en) 2009-04-01
DE602007013234D1 (de) 2011-04-28
US20130317082A1 (en) 2013-11-28
US20100028365A1 (en) 2010-02-04
JP2010500869A (ja) 2010-01-14
ES2361950T3 (es) 2011-06-24

Similar Documents

Publication Publication Date Title
WO2007134210A3 (en) Methods and compositions for the diagnosis and treatment of cancer
WO2008008430A3 (en) Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
EP1765391A4 (en) BACTERIAL COMPOSITIONS FOR THE TREATMENT OF CANCER
WO2007081740A3 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers
CY1120300T1 (el) Αντισωματα ειδικα στην κλαουδινη 6 (cldn6)
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
DE602006014843D1 (de) Verwendung von hif 1alfa modulatoren zur behandlung von krebs
EP1945754A4 (en) Compositions and methods for treating and diagnosing cancer
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
WO2008120098A3 (en) Peptide prodrugs
WO2010099161A8 (en) Micrornas in never-smokers and related materials and methods
EP3064584A3 (en) Micro rna-based methods and compositions for the diagnosis, prognosis and treatmentof gastric cancer
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
WO2009092108A3 (en) Biomarkers for the diagnosis and treatment of pancreatic cancer
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
WO2007081680A3 (en) Microrna expression abnormalities in pancreatic endocrine and acinar tumors
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
ATE471334T1 (de) Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs
WO2007141280A3 (en) Proteins
MX2009010439A (es) Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama.
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
EA201101531A1 (ru) Способ лечения острого миелоидного лейкоза
EP1869212A4 (en) USE OF ID4 TO DIAGNOSE AND TREAT CANCER
DE602004021435D1 (de) Injizierbare zusammensetzung zur behandlung von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties